Entrada Therapeutics Inc —— 季度资产负债表 (NASDAQ:TRDA) | MetaTrader

展开完整图表

新闻

Entrada Therapeutics Q4 每股收益超出预期, 营收低于预期

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada reports progress on DMD treatments, shares clinical timeline

TD Cowen分析师强调2026年10多个潜在生物科技催化剂